AB
PFE icon

Amalgamated Bank’s Pfizer PFE Stock Holding History

Amalgamated Bank’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.9M Sell
993,106
-56,464
-5% -$1.48M 0.17% 84
2026
Q1 		$29.5M Sell
1,049,570
-18,407
-2% -$490K 0.23% 66
2025
Q4 		$26.6M Sell
1,067,977
-15,368
-1% -$388K 0.19% 81
2025
Q3 		$27.6M Sell
1,083,345
-18,098
-2% -$447K 0.2% 83
2025
Q2 		$26.7M Sell
1,101,443
-83
-0% -$1.94K 0.21% 81
2025
Q1 		$27.9M Buy
1,101,526
+16,085
+1% +$421K 0.24% 66
2024
Q4 		$28.8M Sell
1,085,441
-28,055
-3% -$761K 0.24% 64
2024
Q3 		$32.2M Sell
1,113,496
-30,741
-3% -$897K 0.27% 59
2024
Q2 		$32M Sell
1,144,237
-27,091
-2% -$746K 0.27% 54
2024
Q1 		$32.5M Sell
1,171,328
-192,425
-14% -$5.34M 0.28% 54
2023
Q4 		$39.3M Sell
1,363,753
-65,546
-5% -$1.98M 0.31% 45
2023
Q3 		$47.4M Sell
1,429,299
-7,930
-0.6% -$280K 0.4% 34
2023
Q2 		$52.7M Sell
1,437,229
-86,061
-6% -$3.35M 0.43% 33
2023
Q1 		$62.1M Buy
1,523,290
+48,813
+3% +$2.11M 0.53% 26
2022
Q4 		$75.6M Sell
1,474,477
-201,709
-12% -$9.67M 0.67% 20
2022
Q3 		$73.3M Buy
1,676,186
+247,747
+17% +$12M 0.71% 19
2022
Q2 		$74.9M Sell
1,428,439
-54,033
-4% -$2.75M 0.7% 16
2022
Q1 		$76.7M Sell
1,482,472
-91,878
-6% -$4.77M 0.6% 19
2021
Q4 		$93M Buy
1,574,350
+57,831
+4% +$2.87M 0.69% 17
2021
Q3 		$65.2M Sell
1,516,519
-50,360
-3% -$2.23M 0.55% 24
2021
Q2 		$61.4M Buy
1,566,879
+1,262,714
+415% +$49.1M 0.49% 27
2021
Q1 		$11M Sell
304,165
-10,977
-3% -$390K 0.41% 37
2020
Q4 		$11.6M Sell
315,142
-17,862
-5% -$655K 0.44% 32
2020
Q3 		$11.6M Sell
333,004
-6,861
-2% -$241K 0.5% 29
2020
Q2 		$10.5M Sell
339,865
-516,600
-60% -$17.6M 0.49% 32
2020
Q1 		$26.5M Sell
856,465
-32,642
-4% -$1.11M 0.65% 24
2019
Q4 		$33M Buy
889,107
+63,149
+8% +$2.25M 0.61% 26
2019
Q3 		$28.2M Sell
825,958
-17,145
-2% -$623K 0.59% 30
2019
Q2 		$34.7M Buy
843,103
+74,072
+10% +$2.94M 0.81% 17
2019
Q1 		$31M Buy
769,031
+14,112
+2% +$565K 0.75% 19
2018
Q4 		$31.3M Sell
754,919
-15,844
-2% -$658K 0.89% 14
2018
Q3 		$32.2M Sell
770,763
-18,250
-2% -$703K 0.8% 15
2018
Q2 		$27.2M Buy
789,013
+11,719
+2% +$400K 0.66% 21
2018
Q1 		$26.2M Sell
777,294
-9,715
-1% -$334K 0.69% 21
2017
Q4 		$27M Buy
787,009
+69,777
+10% +$2.38M 0.73% 21
2017
Q3 		$24.3M Buy
717,232
+13,270
+2% +$426K 0.76% 17
2017
Q2 		$22.4M Buy
703,962
+256,630
+57% +$8.09M 0.74% 16
2017
Q1 		$14.5M Buy
447,332
+7,757
+2% +$245K 0.72% 18
2016
Q4 		$13.5M Buy
439,575
+120,777
+38% +$3.69M 0.61% 27
2016
Q3 		$10.2M Buy
318,798
+1,493
+0.5% +$49.9K 0.59% 26
2016
Q2 		$10.6M Buy
317,305
+85,941
+37% +$2.74M 0.61% 26
2016
Q1 		$6.51M Buy
231,364
+60,731
+36% +$1.73M 0.63% 20
2015
Q4 		$5.23M Sell
170,633
-55,283
-24% -$1.74M 0.64% 17
2015
Q3 		$6.73M Buy
225,916
+6,447
+3% +$207K 0.71% 14
2015
Q2 		$6.98M Buy
219,469
+7,046
+3% +$230K 0.69% 12
2015
Q1 		$7.01M Buy
212,423
+53,237
+33% +$1.69M 0.86% 12
2014
Q4 		$4.71M Sell
159,186
-26,462
-14% -$759K 0.74% 14
2014
Q3 		$5.21M Buy
185,648
+908
+0.5% +$25.5K 0.78% 15
2014
Q2 		$5.2M Buy
184,740
+13,875
+8% +$396K 0.78% 14
2014
Q1 		$5.21M Sell
170,865
-3,446
-2% -$103K 0.9% 12
2013
Q4 		$5.07M Sell
174,311
-2,006
-1% -$58.4K 0.86% 14
2013
Q3 		$4.8M Sell
176,317
-4,264
-2% -$116K 1.54% 12
2013
Q2 		$4.8M Buy
+180,581
New +$4.99M 1.76% 13

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Amalgamated Bank's PFE Position: Q2 2026 in Review

Amalgamated Bank reduced its Pfizer (PFE) stake by 5.4% in Q2 2026, selling an estimated $1.48M and leaving 993,106 shares worth $23.9M. The position accounts for 0.17% of the portfolio, ranked #84.

Amalgamated Bank first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $93M in Q4 2021. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Amalgamated Bank held 993,106 shares of Pfizer worth $23.9M as of Q2 2026.
  • Amalgamated Bank sold 56,464 Pfizer shares in Q2 2026, an estimated $1.48M.
  • Pfizer made up 0.17% of Amalgamated Bank's portfolio in Q2 2026, its #84 holding.
  • Amalgamated Bank first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Amalgamated Bank's Pfizer position peaked at $93M in Q4 2021.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.